"At the University of New Mexico Comprehensive Cancer Center, our cancer care includes chemotherapy, surgery, radiation therapy, immunotherapy and clinical trials. The UNM Comprehensive Cancer Center is the only one in New Mexico designated by the National Cancer Institute. Learn about our 12 teams who specialize in all types of cancers. Our supportive services assist with cancer genetics counseling, nutritional counseling and more."

During the past decade, University of New Mexico Cancer Center conducted 263 clinical trials. In the 10-year time frame, 263 clinical trials started and 301 clinical trials were completed, i.e. on average, 114.4% percent of trials that started reached the finish line to date. In the past 5 years, 90 clinical trials started and 137 clinical trials were completed. i.e. 152.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of New Mexico Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 160 trials, followed by "Children's Oncology Group" with 118 trials sponsored, "SWOG Cancer Research Network" with 69 trials sponsored, "New Mexico Cancer Care Alliance" with 53 trials sponsored and "Alliance for Clinical Trials in Oncology" with 53 trials sponsored. Other sponsors include 221 different institutions and companies that sponsored additional 93 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of New Mexico Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 351 trials as a collaborator, "NRG Oncology" with 60 trials as a collaborator, "SWOG Cancer Research Network" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator and "NCIC Clinical Trials Group" with 14 trials as a collaborator. Other collaborators include 166 different institutions and companies that were collaborators in the rest 88 trials.

According to Clinical.Site data, the most researched conditions in "University of New Mexico Cancer Center" are "Breast Cancer" (47 trials), "Leukemia" (21 trials), "Prostate Cancer" (17 trials), "Recurrent Ovarian Carcinoma" (16 trials) and "Sarcoma" (16 trials). Many other conditions were trialed in "University of New Mexico Cancer Center" in a lesser frequency.

Most popular intervention types in "University of New Mexico Cancer Center" are "Drug" (520 trials), "Other" (295 trials), "Biological" (193 trials), "Radiation" (140 trials) and "Procedure" (134 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (148 trials), "Quality-of-Life Assessment" (95 trials), "Questionnaire Administration" (66 trials), "Carboplatin" (53 trials) and "Cisplatin" (49 trials). Other intervention names were less common.

The vast majority of trials in "University of New Mexico Cancer Center" are 506 trials for "All" genders, 140 trials for "Female" genders and 27 trials for "Male" genders.

Currently, there are NaN active trials in "University of New Mexico Cancer Center". undefined are not yet recruiting, 102 are recruiting, 191 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 300 completed trials in University of New Mexico Cancer Center, 9 suspended trials, and 55 terminated clinical trials to date.

Out of the total trials that were conducted in University of New Mexico Cancer Center, 56 "Phase 1" clinical trials were conducted, 290 "Phase 2" clinical trials and 290 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 37 trials that are defined as “Not Applicable".